Knockout of miR-221 and miR-222 reveals common and specific targets for paralogous miRNAs

被引:11
作者
Jeong, Geon [1 ,2 ,3 ]
Lim, Yeong-Hwan [1 ,2 ,3 ]
Kim, Nam Joong [1 ,2 ,3 ]
Wee, Gabbine [4 ]
Kim, Young-Kook [1 ,2 ,3 ]
机构
[1] Chonnam Natl Univ, Dept Biochem, Sch Med, Gwangju, South Korea
[2] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Sch Med, Gwangju, South Korea
[3] Chonnam Natl Univ, Basic Res Lab Cardiac Remodeling, Sch Med, Gwangju, South Korea
[4] Daegu Gyeongbuk Med Innovat Fdn, Daegu, South Korea
基金
新加坡国家研究基金会;
关键词
Knockout; microRNA; miR-221; miR-222; TALEN; CARCINOMA-CELL-LINES; MICRORNAS; P27(KIP1); CANCER;
D O I
10.1080/15476286.2016.1269994
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) regulate the expression of mRNA through sequence-specific binding of the 3 untranslated region (UTR). The seed sequence of miRNAs is the key determinant for target site recognition. Paralogous miRNAs, which share the same seed sequences but differ in their 3 regions, are known to regulate largely overlapping groups of mRNAs. However, no study has analyzed functional differences between paralogous miRNAs with proper experimental methods. In this study, we compared the targets of paralogous miRNAs, miR-221 and miR-222. Using a nuclease-mediated genome engineering technique, we established knockout cell lines for these miRNAs, and precisely analyzed differences in target regulation. We found that miR-221 and miR-222 suppress the previously identified targets, CDKN1B and CDKN1C, differentially. Whereas both miRNAs suppressed CDKN1B, only miR-221 suppressed CDKN1C. From transcriptome analyses, we found that several different target mRNAs were regulated by each of miR-221 and miR-222 independently, although a large number of mRNAs responded commonly to miR-221 and miR-222. This is the first study to compare the mRNA regulations by paralogous miRNAs and illustrate that paralogous miRNAs with the same seed sequence also have difference in target regulation.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [1] Targeting the miR-221/miR-222 cluster in cancer therapy
    Brognara, E.
    Fabbri, E.
    Breveglieri, G.
    Finotti, A.
    Bianchi, N.
    Zuccato, C.
    Gambari, R.
    MINERVA BIOTECNOLOGICA, 2014, 26 (02) : 67 - 74
  • [2] Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets
    Sredni, Simone Treiger
    Bonaldo, Maria de Fatima
    Costa, Fabricio Falconi
    Huang, Chiang-Ching
    Hamm, Christopher Allan
    Rajaram, Veena
    Tomita, Tadanori
    Goldman, Stewart
    Bischof, Jared Marshall
    Soares, Marcelo Bento
    CHILDS NERVOUS SYSTEM, 2010, 26 (03) : 279 - 283
  • [3] Severity of Hypertension does not Correlate with Increased miR-221 and miR-222 Expression
    Woods, T. C.
    HYPERTENSION, 2013, 62 (03)
  • [4] The inhibition effect of expressions of miR-221 and miR-222 on glioma and corresponding mechanism
    Zhang, Z.
    Cui, B. Z.
    Wu, L. H.
    Xu, Q. L.
    Wang, Z.
    Yang, B.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (11): : 685 - 691
  • [5] MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
    Zhang, Chun-Zhi
    Zhang, Jun-Xia
    Zhang, An-Ling
    Shi, Zhen-Dong
    Han, Lei
    Jia, Zhi-Fan
    Yang, Wei-Dong
    Wang, Guang-Xiu
    Jiang, Tao
    You, Yong-Ping
    Pu, Pei-Yu
    Cheng, Jin-Quan
    Kang, Chun-Sheng
    MOLECULAR CANCER, 2010, 9
  • [6] Overexpression of miR-221 and miR-222 in the cancer stroma is associated with malignant potential in colorectal cancer
    Iida, Michihisa
    Hazama, Shoichi
    Tsunedomi, Ryouichi
    Tanaka, Hironori
    Takenouchi, Hiroko
    Kanekiyo, Shinsuke
    Tokumitsu, Yukio
    Tomochika, Shinobu
    Tokuhisa, Yoshihiro
    Sakamoto, Kazuhiko
    Suzuki, Nobuaki
    Takeda, Shigeru
    Ueno, Tomio
    Yamamoto, Shigeru
    Yoshino, Shigefumi
    Fujita, Koji
    Kuroda, Masahiko
    Nagano, Hiroaki
    ONCOLOGY REPORTS, 2018, 40 (03) : 1621 - 1631
  • [7] Mir-221/222 are promising targets for innovative anticancer therapy
    Di Martino, Maria Teresa
    Rossi, Marco
    Caracciolo, Daniele
    Gulla, Annamaria
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (09) : 1099 - 1108
  • [8] miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells
    Yang, Chun-Ju
    Shen, Wilma Grace
    Liu, Chung-Ji
    Chen, Yun-Wen
    Lu, Hsuan-Hsuan
    Tsai, Meng-Miao
    Lin, Shu-Chun
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (07) : 560 - 566
  • [9] New molecular biomarkers in differentiated thyroid carcinoma: Impact of miR-146, miR-221 and miR-222 levels in the evolution of the disease
    Maria Gomez-Perez, Ana
    Cornejo Pareja, Isabel Maria
    Garcia Aleman, Jorge
    Coin Araguez, Leticia
    Sebastian Ochoa, Arantzazu
    Alcaide Torres, Juan
    Molina Vega, Maria
    Clu Fernandez, Carlos
    Mancha Doblas, Isabel
    Tinahones, Francisco J.
    CLINICAL ENDOCRINOLOGY, 2019, 91 (01) : 187 - 194
  • [10] miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma
    Karttunen, Jenni
    Kalmar, Lajos
    Grant, Andrew
    Ying, Jun
    Stewart, Sarah E.
    Wang, Xiaonan
    Frankl, Fiona Karet
    Williams, Tim
    SCIENTIFIC REPORTS, 2024, 14 (01):